nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.0079	0.0639	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00485	0.0393	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00475	0.0384	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00369	0.0299	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00362	0.0293	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00294	0.0238	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00288	0.0233	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00284	0.023	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00266	0.0215	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.0026	0.0211	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00224	0.0181	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00219	0.0177	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00202	0.0164	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00198	0.016	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00192	0.0155	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.0019	0.0153	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00188	0.0152	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00186	0.015	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00182	0.0147	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00181	0.00207	CcSEcCtD
Carboprost Tromethamine—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.00181	0.00206	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.0018	0.00206	CcSEcCtD
Carboprost Tromethamine—Cough—Indinavir—acquired immunodeficiency syndrome	0.0018	0.00206	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.0018	0.0146	CbGpPWpGaD
Carboprost Tromethamine—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.0018	0.00205	CcSEcCtD
Carboprost Tromethamine—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00179	0.00204	CcSEcCtD
Carboprost Tromethamine—Pain—Stavudine—acquired immunodeficiency syndrome	0.00179	0.00204	CcSEcCtD
Carboprost Tromethamine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00179	0.00204	CcSEcCtD
Carboprost Tromethamine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00179	0.00204	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.00178	0.00203	CcSEcCtD
Carboprost Tromethamine—Chills—Ritonavir—acquired immunodeficiency syndrome	0.00178	0.00203	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00178	0.0144	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00177	0.00202	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00176	0.0143	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00176	0.00201	CcSEcCtD
Carboprost Tromethamine—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00176	0.00201	CcSEcCtD
Carboprost Tromethamine—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00176	0.00201	CcSEcCtD
Carboprost Tromethamine—Pain—Abacavir—acquired immunodeficiency syndrome	0.00176	0.00201	CcSEcCtD
Carboprost Tromethamine—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00176	0.002	CcSEcCtD
Carboprost Tromethamine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00175	0.002	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00175	0.002	CcSEcCtD
Carboprost Tromethamine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.00175	0.002	CcSEcCtD
Carboprost Tromethamine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00173	0.00197	CcSEcCtD
Carboprost Tromethamine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00173	0.00197	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.00172	0.00196	CcSEcCtD
Carboprost Tromethamine—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00171	0.00196	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00171	0.00195	CcSEcCtD
Carboprost Tromethamine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00171	0.00195	CcSEcCtD
Carboprost Tromethamine—Cough—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.00195	CcSEcCtD
Carboprost Tromethamine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.0017	0.00194	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00169	0.00193	CcSEcCtD
Carboprost Tromethamine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00169	0.00192	CcSEcCtD
Carboprost Tromethamine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00168	0.00192	CcSEcCtD
Carboprost Tromethamine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00168	0.00192	CcSEcCtD
Carboprost Tromethamine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00168	0.00191	CcSEcCtD
Carboprost Tromethamine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00168	0.00191	CcSEcCtD
Carboprost Tromethamine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.00167	0.00191	CcSEcCtD
Carboprost Tromethamine—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00166	0.0019	CcSEcCtD
Carboprost Tromethamine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00166	0.0019	CcSEcCtD
Carboprost Tromethamine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00166	0.0019	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00166	0.0019	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00166	0.0019	CcSEcCtD
Carboprost Tromethamine—Shock—Indinavir—acquired immunodeficiency syndrome	0.00166	0.00189	CcSEcCtD
Carboprost Tromethamine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00166	0.00189	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00166	0.00189	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00165	0.00189	CcSEcCtD
Carboprost Tromethamine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00165	0.00189	CcSEcCtD
Carboprost Tromethamine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00165	0.00188	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00165	0.00188	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00165	0.00188	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00164	0.00187	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00164	0.0133	CbGpPWpGaD
Carboprost Tromethamine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00164	0.00187	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00163	0.00186	CcSEcCtD
Carboprost Tromethamine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00163	0.00186	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00163	0.00186	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00163	0.00186	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00163	0.00186	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00162	0.00185	CcSEcCtD
Carboprost Tromethamine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00161	0.00184	CcSEcCtD
Carboprost Tromethamine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00161	0.00184	CcSEcCtD
Carboprost Tromethamine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00161	0.00184	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00161	0.013	CbGpPWpGaD
Carboprost Tromethamine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.0016	0.00183	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00159	0.00182	CcSEcCtD
Carboprost Tromethamine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00159	0.00182	CcSEcCtD
Carboprost Tromethamine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00159	0.00182	CcSEcCtD
Carboprost Tromethamine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00159	0.00181	CcSEcCtD
Carboprost Tromethamine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00157	0.00179	CcSEcCtD
Carboprost Tromethamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00157	0.00179	CcSEcCtD
Carboprost Tromethamine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00156	0.00178	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00156	0.00178	CcSEcCtD
Carboprost Tromethamine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00155	0.00177	CcSEcCtD
Carboprost Tromethamine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00155	0.00177	CcSEcCtD
Carboprost Tromethamine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00155	0.00177	CcSEcCtD
Carboprost Tromethamine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00155	0.00177	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00154	0.0125	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00154	0.0125	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00154	0.00176	CcSEcCtD
Carboprost Tromethamine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00154	0.00176	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00154	0.00176	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00154	0.00176	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00154	0.00175	CcSEcCtD
Carboprost Tromethamine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00154	0.00175	CcSEcCtD
Carboprost Tromethamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00153	0.00174	CcSEcCtD
Carboprost Tromethamine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00153	0.00174	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00153	0.00174	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00152	0.00173	CcSEcCtD
Carboprost Tromethamine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00152	0.00173	CcSEcCtD
Carboprost Tromethamine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00152	0.00173	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00152	0.00173	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00152	0.00173	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00151	0.00173	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00151	0.0122	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00151	0.0122	CbGpPWpGaD
Carboprost Tromethamine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00151	0.00172	CcSEcCtD
Carboprost Tromethamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00151	0.00172	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00172	CcSEcCtD
Carboprost Tromethamine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.0015	0.00171	CcSEcCtD
Carboprost Tromethamine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.00171	CcSEcCtD
Carboprost Tromethamine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00171	CcSEcCtD
Carboprost Tromethamine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.0015	0.00171	CcSEcCtD
Carboprost Tromethamine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00149	0.00171	CcSEcCtD
Carboprost Tromethamine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00149	0.0017	CcSEcCtD
Carboprost Tromethamine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00149	0.0017	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00149	0.0017	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00148	0.00169	CcSEcCtD
Carboprost Tromethamine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00148	0.00168	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00147	0.00168	CcSEcCtD
Carboprost Tromethamine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00147	0.00168	CcSEcCtD
Carboprost Tromethamine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00147	0.00168	CcSEcCtD
Carboprost Tromethamine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00147	0.00167	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00146	0.00167	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00166	CcSEcCtD
Carboprost Tromethamine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00166	CcSEcCtD
Carboprost Tromethamine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00145	0.00165	CcSEcCtD
Carboprost Tromethamine—Pain—Indinavir—acquired immunodeficiency syndrome	0.00144	0.00165	CcSEcCtD
Carboprost Tromethamine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00144	0.00164	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00143	0.00164	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00143	0.00163	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00143	0.00163	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00143	0.00163	CcSEcCtD
Carboprost Tromethamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00143	0.00163	CcSEcCtD
Carboprost Tromethamine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00143	0.00163	CcSEcCtD
Carboprost Tromethamine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00142	0.00162	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.00162	CcSEcCtD
Carboprost Tromethamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.00162	CcSEcCtD
Carboprost Tromethamine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00162	CcSEcCtD
Carboprost Tromethamine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00162	CcSEcCtD
Carboprost Tromethamine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.00161	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00141	0.00161	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.0014	0.00159	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00139	0.00159	CcSEcCtD
Carboprost Tromethamine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00158	CcSEcCtD
Carboprost Tromethamine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00139	0.00158	CcSEcCtD
Carboprost Tromethamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00138	0.00158	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00138	0.0112	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00138	0.00158	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00157	CcSEcCtD
Carboprost Tromethamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00137	0.00157	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00137	0.00156	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00136	0.00156	CcSEcCtD
Carboprost Tromethamine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00136	0.00156	CcSEcCtD
Carboprost Tromethamine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00136	0.00156	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00136	0.00155	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.00155	CcSEcCtD
Carboprost Tromethamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00136	0.00155	CcSEcCtD
Carboprost Tromethamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.00155	CcSEcCtD
Carboprost Tromethamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00135	0.00155	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00135	0.011	CbGpPWpGaD
Carboprost Tromethamine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00135	0.00154	CcSEcCtD
Carboprost Tromethamine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00135	0.00154	CcSEcCtD
Carboprost Tromethamine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00135	0.00154	CcSEcCtD
Carboprost Tromethamine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00135	0.00154	CcSEcCtD
Carboprost Tromethamine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00152	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00152	CcSEcCtD
Carboprost Tromethamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00133	0.00152	CcSEcCtD
Carboprost Tromethamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00133	0.00151	CcSEcCtD
Carboprost Tromethamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00132	0.00151	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00132	0.00151	CcSEcCtD
Carboprost Tromethamine—Rash—Stavudine—acquired immunodeficiency syndrome	0.00132	0.0015	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00132	0.0015	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00131	0.0015	CcSEcCtD
Carboprost Tromethamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00131	0.0015	CcSEcCtD
Carboprost Tromethamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00131	0.00149	CcSEcCtD
Carboprost Tromethamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00131	0.00149	CcSEcCtD
Carboprost Tromethamine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.0013	0.00149	CcSEcCtD
Carboprost Tromethamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.0013	0.00149	CcSEcCtD
Carboprost Tromethamine—Rash—Abacavir—acquired immunodeficiency syndrome	0.0013	0.00148	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.0013	0.00148	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.00148	CcSEcCtD
Carboprost Tromethamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00129	0.00147	CcSEcCtD
Carboprost Tromethamine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00147	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00129	0.00147	CcSEcCtD
Carboprost Tromethamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00128	0.00147	CcSEcCtD
Carboprost Tromethamine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00145	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.00145	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.00144	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00144	CcSEcCtD
Carboprost Tromethamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00143	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.00143	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00125	0.0101	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00124	0.00142	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00124	0.00142	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00142	CcSEcCtD
Carboprost Tromethamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00124	0.00141	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00124	0.00141	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00124	0.01	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00122	0.00991	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00122	0.00139	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.00139	CcSEcCtD
Carboprost Tromethamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00121	0.00138	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00138	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00121	0.00978	CbGpPWpGaD
Carboprost Tromethamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00138	CcSEcCtD
Carboprost Tromethamine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00121	0.00138	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00138	CcSEcCtD
Carboprost Tromethamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.0012	0.00137	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.00135	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00118	0.00951	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00118	0.00951	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00134	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00117	0.00951	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00133	CcSEcCtD
Carboprost Tromethamine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00116	0.00132	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00132	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00132	CcSEcCtD
Carboprost Tromethamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00115	0.00132	CcSEcCtD
Carboprost Tromethamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00131	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00115	0.00931	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00115	0.00931	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00115	0.0093	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00115	0.0093	CbGpPWpGaD
Carboprost Tromethamine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00114	0.00131	CcSEcCtD
Carboprost Tromethamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00114	0.00131	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00114	0.0013	CcSEcCtD
Carboprost Tromethamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00114	0.0013	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00112	0.0091	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.00128	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00112	0.00906	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00112	0.00127	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00127	CcSEcCtD
Carboprost Tromethamine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00126	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.0011	0.00887	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00109	0.00125	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00124	CcSEcCtD
Carboprost Tromethamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00108	0.00123	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00122	CcSEcCtD
Carboprost Tromethamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00107	0.00122	CcSEcCtD
Carboprost Tromethamine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00121	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00121	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00106	0.00856	CbGpPWpGaD
Carboprost Tromethamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00121	CcSEcCtD
Carboprost Tromethamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.0012	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00119	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00119	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00104	0.00841	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00104	0.00838	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00117	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00102	0.00823	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00116	CcSEcCtD
Carboprost Tromethamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00101	0.00115	CcSEcCtD
Carboprost Tromethamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00115	CcSEcCtD
Carboprost Tromethamine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00115	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.001	0.00115	CcSEcCtD
Carboprost Tromethamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.001	0.00114	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.001	0.00114	CcSEcCtD
Carboprost Tromethamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000999	0.00114	CcSEcCtD
Carboprost Tromethamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000974	0.00111	CcSEcCtD
Carboprost Tromethamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00097	0.00111	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000965	0.0011	CcSEcCtD
Carboprost Tromethamine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000962	0.0011	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000961	0.0011	CcSEcCtD
Carboprost Tromethamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000956	0.00109	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000954	0.00109	CcSEcCtD
Carboprost Tromethamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000947	0.00108	CcSEcCtD
Carboprost Tromethamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000933	0.00106	CcSEcCtD
Carboprost Tromethamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000929	0.00106	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000929	0.00106	CcSEcCtD
Carboprost Tromethamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000906	0.00103	CcSEcCtD
Carboprost Tromethamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000898	0.00102	CcSEcCtD
Carboprost Tromethamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000897	0.00102	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000894	0.00724	CbGpPWpGaD
Carboprost Tromethamine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00089	0.00101	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000889	0.00101	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000886	0.00101	CcSEcCtD
Carboprost Tromethamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000884	0.00101	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000875	0.00709	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000863	0.000985	CcSEcCtD
Carboprost Tromethamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000857	0.000977	CcSEcCtD
Carboprost Tromethamine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000856	0.000977	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000855	0.000976	CcSEcCtD
Carboprost Tromethamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000851	0.000971	CcSEcCtD
Carboprost Tromethamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000838	0.000956	CcSEcCtD
Carboprost Tromethamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000824	0.00094	CcSEcCtD
Carboprost Tromethamine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000817	0.000932	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000816	0.000931	CcSEcCtD
Carboprost Tromethamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000811	0.000926	CcSEcCtD
Carboprost Tromethamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000807	0.00092	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000806	0.00652	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000789	0.00638	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000769	0.000878	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00071	0.00574	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000707	0.00572	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000695	0.00562	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000692	0.0056	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000678	0.00549	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000678	0.00549	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000664	0.00538	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000664	0.00538	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000664	0.00537	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000664	0.00537	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00065	0.00526	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00065	0.00526	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000642	0.00519	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000628	0.00508	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000614	0.00497	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000603	0.00488	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000603	0.00488	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000601	0.00486	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000591	0.00478	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000591	0.00478	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000505	0.00409	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000498	0.00403	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000495	0.004	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000487	0.00394	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000485	0.00393	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000475	0.00384	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000459	0.00371	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000455	0.00369	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000452	0.00366	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000449	0.00364	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000446	0.00361	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000443	0.00358	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000419	0.00339	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000414	0.00335	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00041	0.00332	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000405	0.00328	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000379	0.00307	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000371	0.003	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000356	0.00288	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000356	0.00288	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000349	0.00282	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000349	0.00282	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000271	0.00219	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000267	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000265	0.00215	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000263	0.00213	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000261	0.00212	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000258	0.00208	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000244	0.00198	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000239	0.00194	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000239	0.00193	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000234	0.00189	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000141	0.00114	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00014	0.00114	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000138	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000137	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.3e-05	0.000671	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.12e-05	0.000657	CbGpPWpGaD
